Pitt Street Research | Stock research

Roquefort Therapeutics

Roquefort Therapeutics plc is listed on the London Stock Exchange (LSE:ROQ). It is a drug developer focused on the therapeutic potential of a protein called Midkine, which may be useful as a target in the treatment of severe inflammatory and autoimmune disorders, and cancer, among other disease conditions.

Roquefort Therapeutics (LSE:ROQ)

 

Roquefort Therapeutics plc is listed on the London Stock Exchange (LSE:ROQ). It is a drug developer focused on the therapeutic potential of a protein called Midkine, which may be useful as a target in the treatment of severe inflammatory and autoimmune disorders, and cancer, among other disease conditions.